Weaver C. Barksdale & Associates’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$11K	Buy	97 +5	+5%	+$544	0.01%	261
2017 Q3	$10K	Sell	92 -6	-6%	-$616	0.01%	270
2017 Q2	$10K	Sell	98 -19	-16%	-$1.75K	0.01%	266
2017 Q1	$11K	Hold	117	–	–	0.01%	257
2016 Q4	$9K	Buy	117 +28	+31%	+$2.13K	0.01%	287
2016 Q3	$7K	Buy	89 +17	+24%	+$1.43K	0.01%	319
2016 Q2	$6K	Hold	72	–	–	0.01%	329
2016 Q1	$5K	Hold	72	–	–	﹤0.01%	379
2015 Q4	$6K	Sell	72 -11	-13%	-$793	﹤0.01%	344
2015 Q3	$5K	Hold	83	–	–	﹤0.01%	373
2015 Q2	$6K	Hold	83	–	–	﹤0.01%	353
2015 Q1	$7K	Hold	83	–	–	0.01%	332
2014 Q4	$5K	Sell	83 -7	-8%	-$439	﹤0.01%	372
2014 Q3	$5K	Sell	90 -5	-5%	-$286	﹤0.01%	361
2014 Q2	$5K	Buy	95 +13	+16%	+$713	﹤0.01%	378
2014 Q1	$5K	Sell	82 -18	-18%	-$1.05K	﹤0.01%	373
2013 Q4	$5K	Hold	100	–	–	﹤0.01%	376
2013 Q3	$5K	Sell	100 -9	-8%	-$413	﹤0.01%	371
2013 Q2	$4K	Buy	+109	New	+$4.67K	﹤0.01%	400